comparemela.com

Latest Breaking News On - Castle biosciences - Page 17 : comparemela.com

Castle Biosciences Expects FY23 Revenue To Exceed $210 Mln, Surpassing Previous Outlook

Castle Biosciences Inc. (CSTL) expects to deliver more than $210 million in revenue for fiscal year 2023, exceeding the floor of its guidance of at least $200 million.

Commerce department onTransportation security administrationUs department of transportationCommerce departmentCastle biosciences

Castle Biosciences raises FY23 revenue, to exceed $210M above consensus

Castle Biosciences raises FY23 revenue, to exceed $210M above consensus
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Castle biosciences

It s JPM time! Which medtechs are expected to issue updates this week? (NASDAQ:ILMN)

It s JPM time! Which medtechs are expected to issue updates this week? (NASDAQ:ILMN)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesCastle biosciencesDentsply sironaPacific biosciencesCanaccord genuitySight sciencesAdvisory committeeBreast healthGuardant healthHealthcare conferenceExact sciencesNanostring technologiesAkoya biosciencesLucid diagnostics

12 Health Care Stocks Moving In Monday s Pre-Market Session - AlloVir (NASDAQ:ALVR), Atara Biotherapeutics (NASDAQ:ATRA)

Cidara therapeuticsTrinity biotechCyclacel pharmaceuticalsKaruna therapeuticsCastle biosciences

Derek J Maetzold Sells 5,201 Shares of Castle Biosciences, Inc (NASDAQ:CSTL) Stock

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 5,201 shares of the stock in a transaction that occurred on Wednesday, December 20th. The shares were sold at an average price of $21.05, for a total value of $109,481.05. Following the completion of the sale, the insider now directly owns 97,517 […]

Derekj maetzoldCastle biosciencesBlackrock incPrincipal financial group incGranahan investment managementWasatch advisors incCastle biosciences incGet free reportBiosciences trading downInvestment managementPrincipal financial groupFinancial groupCastle biosciences dailyNasdaq cstlInsider tradingNsider trades

vimarsana © 2020. All Rights Reserved.